13F Filings History of Kohlberg Kravis Roberts & Co. L.P.

Latest 13F report
Q3 2025 - 14 Nov 2025
Value $
$5,967,415,588
Signature - Title
Lew Breckenridge - Managing Director
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by Kohlberg Kravis Roberts & Co. L.P.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Kohlberg Kravis Roberts & Co. L.P. reported 85 stock holdings with total value $5,967,415,588 as of Q3 2025. Top holdings included BTSG, HSIC, BBIO, NIQ, and PSKY.

Notify me when Kohlberg Kravis Roberts & Co. L.P. files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2025 85 $5,967,415,588 +$878,734,423 -$196,203,999 +$682,530,424 BTSG, HSIC, BBIO, NIQ, PSKY 13F-HR 14 Nov 2025, 12:04
Q2 2025 76 $4,839,893,717 +$590,138,229 -$1,002,416,093 -$412,277,864 BTSG, HSIC, BBIO, BV, CRGY 13F-HR 14 Aug 2025, 13:39
Q1 2025 75 $4,427,070,268 +$990,839,659 -$459,038,559 +$531,801,100 BTSG, HSIC, BBIO, BV, KREF 13F-HR 15 May 2025, 14:20
Q4 2024 68 $3,734,469,417 +$60,078,455 -$4,080,232,476 -$4,020,154,021 BTSG, BBIO, BV, KREF, DASH 13F-HR 14 Feb 2025, 12:35
Q3 2024 72 $7,468,046,124 +$3,946,836,607 -$340,250,728 +$3,606,585,879 OS, BTSG, BBIO, BV, PGRU 13F-HR 14 Nov 2024, 15:01
Q2 2024 69 $3,333,611,590 +$165,398,844 -$649,538,979 -$484,140,135 BTSG, BBIO, BV, PGRU, KREF 13F-HR 14 Aug 2024, 16:55
Q1 2024 67 $3,877,190,050 +$1,042,774,265 -$649,545,863 +$393,228,402 BBIO, BTSG, BV, PGRU, TGAN 13F-HR 15 May 2024, 15:54
Q4 2023 71 $3,383,953,514 +$128,480,357 -$169,513,681 -$41,033,324 BBIO, BV, FSK, APP, PGRU 13F-HR 14 Feb 2024, 14:39
Q3 2023 73 $2,849,240,667 +$148,157,070 -$1,149,760,399 -$1,001,603,329 BBIO, BV, FSK, APP, PGRU Restatement 22 Jan 2024, 10:27
Q2 2023 71 $3,228,936,080 +$134,545,454 -$931,859,318 -$797,313,864 APP, BBIO, FSK, BV, PGRU 13F-HR 14 Aug 2023, 10:35
Q1 2023 82 $3,322,438,964 +$88,404,353 -$283,482,273 -$195,077,920 APP, BBIO, FSK, BV, PGRU 13F-HR 15 May 2023, 15:42
Q4 2022 126 $2,963,177,302 +$155,421,012 -$1,527,502,199 -$1,372,081,187 APP, BV, FSK, BBIO, EDR 13F-HR 14 Feb 2023, 12:08
Q3 2022 213 $4,979,078,000 +$66,215,345 -$1,611,281,487 -$1,545,066,142 APP, FI, BV, LAUR, FSK 13F-HR 14 Nov 2022, 10:08
Q2 2022 263 $7,521,315,000 +$169,104,748 -$1,281,903,283 -$1,112,798,535 FI, APP, BV, FSK, LAUR 13F-HR 12 Aug 2022, 16:12
Q1 2022 276 $11,028,764,000 +$919,725,435 -$3,759,600,070 -$2,839,874,635 APP, FI, BV, FSK, EDR 13F-HR 16 May 2022, 16:48
Q4 2021 208 $18,227,569,000 +$546,517,055 -$3,394,338,122 -$2,847,821,067 APP, FI, EDR, BV, KNBE 13F-HR 14 Feb 2022, 14:09
Q3 2021 185 $19,903,292,000 +$390,162,078 -$4,181,984,027 -$3,791,821,949 APP, FI, BBIO, BV, KNBE 13F-HR 15 Nov 2021, 17:07
Q2 2021 141 $24,656,570,158 +$10,478,541,512 -$5,332,195,944 +$5,146,345,568 APP, FI, BBIO, IR, ASO 13F-HR 16 Aug 2021, 14:14
Q1 2021 101 $19,849,035,000 +$376,064,334 -$1,409,968,674 -$1,033,904,340 FI, IR, BBIO, ASO, BV 13F-HR 17 May 2021, 16:41
Q4 2020 60 $19,711,494,000 +$1,507,181,977 -$2,771,086,915 -$1,263,904,938 FI, BBIO, IR, ASO, BV 13F-HR 16 Feb 2021, 17:01
Q3 2020 65 $17,345,596,000 +$607,870,963 -$930,217,765 -$322,346,802 FI, IR, BBIO, BV, KREF 13F-HR 16 Nov 2020, 17:00
Q2 2020 67 $16,338,898,000 +$710,521,975 -$1,097,555,683 -$387,033,708 FI, IR, BBIO, BV, KREF 13F-HR 14 Aug 2020, 17:02
Q1 2020 50 $15,675,408,000 +$1,967,670,526 -$3,111,412,430 -$1,143,741,904 FI, IR, BBIO, BV, KREF 13F-HR 15 May 2020, 17:19
Q4 2019 54 $20,455,805,000 +$362,875,391 -$309,553,014 +$53,322,377 FI, GDI, BBIO, BV, KREF 13F-HR 14 Feb 2020, 16:01
Q3 2019 52 $17,777,694,000 +$11,705,540,185 -$1,264,585,842 +$10,440,954,343 FI, GDI, BV, BBIO, KREF 13F-HR 14 Nov 2019, 16:02
Q2 2019 55 $8,117,692,000 +$1,224,607,117 -$299,700,978 +$924,906,139 GDI, BV, BBIO, PRAH, KREF 13F-HR 14 Aug 2019, 16:00
Q1 2019 55 $6,572,745,000 +$748,874,942 -$732,746,453 +$16,128,489 GDI, BV, PRAH, KREF, FOCS 13F-HR 15 May 2019, 16:01
Q4 2018 56 $5,483,174,000 +$537,282,892 -$1,636,099,258 -$1,098,816,366 GDI, PRAH, BV, KREF, EYE 13F-HR 13 Feb 2019, 16:06
Q3 2018 57 $8,805,734,000 +$1,395,404,361 -$1,820,621,030 -$425,216,669 GDI, BV, EYE, PRAH, KREF 13F-HR 14 Nov 2018, 16:03
Q2 2018 51 $8,782,218,000 +$1,842,877,841 -$1,620,015,832 +$222,862,009 GDI, BV, PRAH, EYE, KREF 13F-HR 14 Aug 2018, 16:02
Q1 2018 42 $8,223,848,000 +$228,190,010 -$1,396,405,735 -$1,168,215,725 GDI, PRAH, EYE, KREF, GDDY 13F-HR 15 May 2018, 16:05
Q4 2017 49 $10,112,034,000 +$2,319,055,388 -$1,910,799,601 +$408,255,787 GDI, EYE, PRAH, KREF, GDDY 13F-HR 14 Feb 2018, 16:30
Q3 2017 1 $73,501,000 $0 $0 $0 WRD New Holdings 14 Feb 2018, 16:37
Q3 2017 51 $8,647,830,000 +$352,023,339 -$1,500,134,364 -$1,148,111,025 GDI, PRAH, USFD, KREF, GDDY 13F-HR 14 Nov 2017, 16:23
Q2 2017 1 $68,259,000 $0 $0 $0 WRD New Holdings 14 Feb 2018, 16:25
Q2 2017 2 $510,857,000 $0 $0 $0 KREF, VRS New Holdings 14 Nov 2017, 16:15
Q2 2017 47 $8,827,625,000 +$4,101,019,914 -$1,109,450,326 +$2,991,569,588 GDI, PRAH, USFD, KREF, GDDY 13F-HR 14 Aug 2017, 16:05
Q1 2017 1 $60,000 $0 $0 $0 VRS New Holdings 14 Nov 2017, 16:08
Q1 2017 1 $9,790,000 $0 $0 $0 NOMD New Holdings 29 Jun 2017, 17:00
Q1 2017 50 $5,562,855,000 +$288,665,474 -$1,372,869,384 -$1,084,203,910 USFD, PRAH, GDDY, EGL, AMED 13F-HR 15 May 2017, 16:32
Q4 2016 1 $71,000 $0 $0 $0 VRS New Holdings 14 Nov 2017, 16:05
Q4 2016 53 $6,263,582,000 +$615,458,758 -$2,695,119,382 -$2,079,660,624 USFD, PRAH, GDDY, HCA, EGL 13F-HR 14 Feb 2017, 16:33
Q3 2016 1 $65,000 $0 $0 $0 VRS New Holdings 14 Nov 2017, 16:02
Q3 2016 55 $8,027,065,000 +$497,478,000 -$2,317,801,904 -$1,820,323,904 USFD, WBA, PRAH, GDDY, HCA 13F-HR 14 Nov 2016, 16:46
Q2 2016 49 $9,373,679,000 +$2,562,145,581 -$3,235,023,983 -$672,878,402 WBA, USFD, PRAH, GDDY, ZBH 13F-HR 15 Aug 2016, 17:11
Q1 2016 50 $10,060,887,000 +$304,029,177 -$413,976,311 -$109,947,134 WBA, PRAH, HCA, ZBH, GDDY 13F-HR 16 May 2016, 17:23
Q4 2015 54 $10,269,233,000 +$880,865,367 -$471,978,622 +$408,886,745 WBA, PRAH, HCA, ZBH, GDDY Restatement 01 Apr 2016, 17:18
Q3 2015 67 $9,402,526,000 +$461,201,194 -$1,591,293,692 -$1,130,092,498 WBA, PRAH, HCA, ZBH, GDDY Restatement 01 Apr 2016, 17:07
Q2 2015 56 $11,053,859,000 +$1,724,346,969 -$724,802,860 +$999,544,109 WBA, PRAH, HCA, SJM, ZBH Restatement 01 Apr 2016, 17:05
Q1 2015 84 $9,614,168,000 +$1,816,610,552 -$387,387,985 +$1,429,222,567 WBA, PRAH, HCA, SJM, NLSN 13F-HR 15 May 2015, 16:49
Q4 2014 74 $7,625,871,000 +$5,090,715,984 -$881,604,097 +$4,209,111,887 WBA, HCA, PRAH, NLSN, RNET 13F-HR 17 Feb 2015, 17:04
Q3 2014 82 $3,317,797,000 +$505,977,539 -$485,929,511 +$20,048,028 HCA, NLSN, WAG, RNET, KKR 13F-HR 14 Nov 2014, 17:22
Q2 2014 75 $3,376,338,000 +$462,325,019 -$3,027,775,108 -$2,565,450,089 HCA, NLSN, WAG, RNET, KKR 13F-HR 14 Aug 2014, 16:38
Q1 2014 129 $5,748,556,000 +$1,035,713,163 -$1,539,020,309 -$503,307,146 HCA, NLSN, MRVL, NXPI, WAG Restatement 14 Aug 2014, 16:33
Q4 2013 115 $5,825,975,000 $0 $0 $0 HCA, NLSN, NXPI, MRVL, JAZZ 13F-HR 14 Feb 2014, 16:20